secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVRx, Inc. (CVRX)
CIK:        0001235912
Form:       8-K
Filed at:   2025-02-04T23:59:59+00:00
Accession:  0001104659-25-009115
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVRx Q4 2024 revenue $15.3M (+36% YoY); FY2025 revenue guidance $63-65M
-----------------------------------------------------------------------

- Q4 2024 total revenue $15.3M, +36% YoY; U.S. HF revenue $14.3M, +41% YoY (457 units vs 330).
- FY2024 total revenue $51.3M, +31% YoY; net loss $60.0M ($2.65 per share) vs $41.2M in FY2023.
- Active implanting centers grew to 223 as of Dec 31, 2024, up 25% from 178 a year earlier.
- FY2025 guidance: total revenue $63-65M, gross margin 83-84%, operating expenses $100-104M.
- Cash and cash equivalents $105.9M as of Dec 31, 2024; net cash used in ops/investing $40.5M in FY2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1235912/000110465925009115/0001104659-25-009115-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1235912/000110465925009115/tm255369d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-009115

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer